# Targeted Microbiome Transplant in Atopic Dermatitis

> **NCT03151148** · PHASE1,PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 54 (actual)

## Conditions studied

- Atopic Dermatitis (AD)

## Interventions

- **BIOLOGICAL:** TMT Lotion
- **DRUG:** Placebo Lotion

## Key facts

- **NCT ID:** NCT03151148
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-28
- **Primary completion:** 2019-05-14
- **Final completion:** 2019-06-07
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2020-08-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03151148

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03151148, "Targeted Microbiome Transplant in Atopic Dermatitis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03151148. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*